Clinical Research Directory
Browse clinical research sites, groups, and studies.
Dexmedetomidine for Intraoperative Shivering in Scheduled Elective Cesarean Delivery
Sponsor: Mayo Clinic
Summary
The purpose of this study is to determine the optimum dose of Dexmedetomidine to stop shivering in 90% of patients who experience shivering during scheduled elective cesarean deliveries.
Official title: Dexmedetomidine for Treatment of Shivering During Scheduled Elective Cesarean Delivery: Determining the Optimal Dose
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2021-09-21
Completion Date
2026-08
Last Updated
2025-09-11
Healthy Volunteers
No
Conditions
Interventions
Dexmedetomidine
Doses of dexmedetomidine will be selected according to a sequential up-and-down method, using a biased coin design to find the estimated dose at which 90% of patients would have desired effect
Locations (1)
Mayo Clinic in Rochester
Rochester, Minnesota, United States